Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19

Gastroenterology. 2021 Mar;160(4):1012-1013. doi: 10.1053/j.gastro.2020.12.050. Epub 2020 Dec 30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Liver Transplantation*
  • SARS-CoV-2
  • Tacrolimus / adverse effects

Substances

  • Immunosuppressive Agents
  • Tacrolimus